Kia Nobre steps down as Head of Department
10 January 2022
Matthew Rushworth replaces Kia Nobre as interim Head of the Department of Experimental Psychology
Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity
10 January 2022
Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.
New spinout company: Human-Centric Drug Discovery
7 January 2022
Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.
Funding received for research into Motor Neuron Disease
5 January 2022
A £210,000 donation from the Alan Davidson Foundation has been made to the Nuffield Department of Clinical Neurosciences to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.
New Year's Honours for Professor Irene Tracey
4 January 2022
Professor Irene Tracey FMedSci, MAE, Professor of Anaesthetic Neuroscience and Warden of Merton College, has been appointed CBE for services to medical research.
Recognition of Distinction Awards 2021
15 December 2021
It is a great pleasure to announce that a number of Neuroscience researchers have been successful in the recent assessment process for the conferment of the title of full Professor.
New Research Highlights Importance of Early Years Development on Future Wellbeing
25 November 2021
Oxford researchers involved nearly 4,000 children across the UK in three specially developed science lessons to educate pupils about brain development during early childhood. The SEEN (Secondary Education around Early Neurodevelopment) project was commissioned and funded by KindredSquared and is part of a wider drive to increase public understanding of how early experiences can shape the adults we become.
Evaluating risk to people with epilepsy during the COVID-19 pandemic - study wins international prize
19 November 2021
Awards and Honours Research Highlights
In May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.
Oxfordshire Young People Involved in Childline Research Project
4 November 2021
New research conducted by the Neuroscience, Ethics and Society group and NeurOX Young People’s Advisory Group in the Department of Psychiatry at the University of Oxford, and the NSPCC, has looked at how Childline’s message boards help support young people.
New European initiative to accelerate the discovery and validation of biomarkers for neurodegenerative diseases
3 November 2021
Research Highlights Strategic Developments
Members of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
28th British Isles Research Workshop on Suicide and Self-Harm & Lancet Psychiatry Suicide Symposium
2 November 2021
This year's annual meeting focused again on research related to the impact of the COVID-19 pandemic on suicide and self-harm. There was another session on online safety in the context of suicidal behaviour and the Online Safety Bill. Organised by the Centre for Suicide Research, University of Oxford, these virtual workshops for both senior and early career researchers from the UK and Ireland provide an important opportunity to share knowledge and discuss the latest research. This year there were also contributions from Australia and Denmark.
Experimental Medicine and Industry Partnership
1 November 2021
The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.
PTSD in healthcare workers during pandemic could be exacerbated by past trauma
29 October 2021
While some of the high rates of post-traumatic stress (PTSD) seen in healthcare workers during the pandemic are specifically COVID-19-related, a more significant number of cases were linked to trauma that occurred earlier in their lives, researchers at the University of Oxford have found.
Major research network to investigate body clock and stroke
27 October 2021
Major Funding Awards Research Highlights Strategic Developments
The University of Oxford is part of a new international research network to investigate the interactions between the biology of the body's internal clock and the disordered physiological processes associated with stroke.
Mapping uncharted networks in the progression of Parkinson’s
27 October 2021
Major Funding Awards Strategic Developments
A major new $9 million project funded by the Aligning Science Across Parkinson’s (ASAP) initiative will map the original circuits vulnerable to Parkinson’s on an unprecedented scale. The project is a collaboration between a core team of Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institute, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
What is the Role of Science in Mental Health?
26 October 2021
A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.
New Policy Briefing Addresses Mental Health Effects of the Pandemic on Young People
26 October 2021
In the Briefing, a team of researchers at King’s College London and Oxford University highlight the multiple effects that the COVID-19 pandemic has had on children and young people in the UK in their education and daily life, including challenges around social isolation, academic pressures, adjusting to online learning and coping with reopening of schools.